Enjoy a facial like experience with clinical grade results
Wound & injury healing Each peptide individually studied in animal models of wound closure and injury recovery
As of mid-2026, Retatrutide is still in Phase 3 trials, with FDA approval expected late this year or early next
Absorption Breakthroughs Oral Delivery Barriers of L-Glutathione Oral L-glutathione faces three almost insurmountable physiological barriers, resulting in low bioavailability
Some patients benefit from more frequent, protein-rich meals to maintain stable blood glucose and energy availability without exceeding appetite suppression
GLP-1 receptor agonists, now established as an extremely potent therapy for managing type 2 diabetes and obesity, are based on gut-derived peptides, and have profound, albeit variable, effects to slow gastric emptying